DMRA · Damora Therapeutics, Inc. · Fails to Deliver
$23.22
-1.08 (-4.44%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 4, 2026
Market Cap
$1.44B
Shares
61.90M
Volume · Nov 20
643.39K
Avg daily vol (3M)
577.78K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-26 | 147 | $21.09 | $3,100 |
| 2026-10-22 | 2,173 | $21.53 | $46,785 |
| 2026-10-19 | 36,631 | $18.44 | $675,476 |
| 2026-10-15 | 329 | $18.43 | $6,063 |
| 2026-10-09 | 333 | $20.56 | $6,846 |
| 2026-10-06 | 202 | $20.22 | $4,084 |
| 2026-10-01 | 778 | $21.28 | $16,556 |
| 2026-09-21 | 27,088 | $22.59 | $611,918 |
| 2026-09-17 | 16,999 | $24.53 | $416,985 |
| 2026-09-16 | 151,705 | $24.75 | $3,754,699 |
| 2026-09-10 | 36,541 | $26.27 | $959,932 |
| 2026-09-09 | 13,006 | $29.17 | $379,385 |
| 2026-09-02 | 3,250 | $28.14 | $91,455 |
| 2026-08-24 | 5,444 | $30.82 | $167,784 |
Showing 1–14 of 14 settlements
Key facts
CIK
1800315
CUSIP
G2646Y104
13F (30d)
115 filings
112 filers
Visit website
Investor relations